{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:58Z","timestamp":1793978878550,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcrp.2026.200684","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:38:40Z","timestamp":1784245120000},"page":"200684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk stacking in peripheral artery disease (PAD): Integrating genetics, cardiometabolic disease and social determinants of health to explain worsening PAD outcomes"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-4563","authenticated-orcid":false,"given":"Matthew","family":"Nudy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Sinoway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcrp.2026.200684_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob Heart"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200684_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12933-024-02324-w","article-title":"Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes","volume":"23","author":"Shah","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200684_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/SLA.0000000000006813","article-title":"Turning tides: evolving comorbidity profiles, demographic shift, and the unexpected rise of major lower extremity amputations","volume":"282","author":"Kougias","year":"2025","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijcrp.2026.200684_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"3rd. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann. Intern. Med."},{"issue":"25 Suppl 2","key":"10.1016\/j.ijcrp.2026.200684_bib5","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ijcrp.2026.200684_bib6","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200684_bib7","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American heart association's construct of cardiovascular health: a presidential advisory from the American heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ijcrp.2026.200684_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200684_bib9","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.jvs.2025.07.033","article-title":"The majority of patients undergoing major leg amputations for chronic limb-threatening ischemia do not undergo revascularization prior to amputation and have increased mortality","volume":"82","author":"Ali","year":"2025","journal-title":"J. Vasc. Surg."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200684_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jamaneurol.2017.0020","article-title":"Prevalence of cardiovascular risk factors and strokes in younger adults","volume":"74","author":"George","year":"2017","journal-title":"JAMA Neurol."},{"issue":"13","key":"10.1016\/j.ijcrp.2026.200684_bib11","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.1920391117","article-title":"US life expectancy stalls due to cardiovascular disease, not drug deaths","volume":"117","author":"Mehta","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200684_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/ans.15121","article-title":"Endovascular interventions are increasing to meet the clinical demands of modern peripheral arterial disease patients","volume":"89","author":"Marron","year":"2019","journal-title":"ANZ J. Surg."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200684_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200684_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0021-9150(02)00026-6","article-title":"Lipoprotein (a) as a predictor of coronary heart disease: the PRIME study","volume":"163","author":"Luc","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcrp.2026.200684_bib15","article-title":"Case study: Lipoprotein (a) and its role in cardiovascular risk","author":"Singh","year":"2020","journal-title":"National Lipid Association"},{"issue":"23","key":"10.1016\/j.ijcrp.2026.200684_bib16","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200684_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101662","article-title":"Lipoprotein (a) distribution in aortic stenosis patients: are lp(a) reducing agents the ultimate solution?","volume":"4","author":"Durr","year":"2025","journal-title":"JACC Adv"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200684_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/AOG.0000000000005862","article-title":"Long-Term changes to cardiovascular biomarkers after hormone therapy in the women's health initiative hormone therapy clinical trials","volume":"145","author":"Nudy","year":"2025","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200684_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd12050171","article-title":"Non-traditional cardiovascular risk factors: tailored assessment and clinical implications","volume":"12","author":"Perone","year":"2025","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200684_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2022.06.019","article-title":"Ancestry, Lipoprotein(a), and cardiovascular risk thresholds: JACC review topic of the week","volume":"80","author":"Tsimikas","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200684_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacc.2021.10.044","article-title":"Association of Lipoprotein(a) with atherosclerotic plaque progression","volume":"79","author":"Kaiser","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200684_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014611","article-title":"Association of Lipoprotein (a) with coronary-computed tomography angiography-assessed high-risk coronary disease attributes and cardiovascular outcomes","volume":"15","author":"Dai","year":"2022","journal-title":"Circ., Cardiovasc. Imaging"},{"issue":"24","key":"10.1016\/j.ijcrp.2026.200684_bib23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.jacc.2023.10.009","article-title":"Lipoprotein(a) and risks of peripheral artery disease, abdominal aortic aneurysm, and major adverse limb events","volume":"82","author":"Thomas","year":"2023","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"issue":"24","key":"10.1016\/j.ijcrp.2026.200684_bib24","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.jacc.2023.10.009","article-title":"Lipoprotein(a) and risks of peripheral artery disease, abdominal aortic aneurysm, and major adverse limb events","volume":"82","author":"Thomas","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200684_bib25","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/01.CIR.0000012146.07240.FD","article-title":"Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene","volume":"105","author":"Morishita","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200684_bib26","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20175979","article-title":"Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease","volume":"50","author":"Fan","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200684_bib27","article-title":"Lipoprotein(a) as an independent biomarker of coronary complexity: prevalence, clinical correlates, and diagnostic utility in a north Indian acute coronary Syndrome cohort","volume":"17","author":"Mahajan","year":"2025","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200684_bib28","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ijcrp.2026.200684_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117313","article-title":"Lipid-lowering in diabetes: an update","volume":"394","author":"Chait","year":"2024","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200684_bib30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.119.315939","article-title":"Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis","volume":"126","author":"Tabas","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200684_bib31","article-title":"Thin-Cap fibroatheroma rather than any lipid plaques increases the risk of cardiovascular events in diabetic patients: insights from the COMBINE OCT\u2013FFR trial","volume":"15","author":"Fabris","year":"2022","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200684_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13061291","article-title":"Atherosclerosis and insulin resistance: is there a link between them?","volume":"13","author":"Brie","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200684_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12872-025-04687-8","article-title":"Clinical risk score to predict poor coronary collateralization in type 2 diabetic patients with chronic total occlusion","volume":"25","author":"Mao","year":"2025","journal-title":"BMC Cardiovasc. Disord."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200684_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12933-018-0671-6","article-title":"Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion","volume":"17","author":"Shen","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200684_bib35","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2337\/dc18-2266","article-title":"Prevalence and prognosis of unrecognized myocardial infarction in asymptomatic patients with diabetes: a two-center Study with up to 5 years of Follow-up","volume":"42","author":"Elliott","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200684_bib36","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/15385744251355230","article-title":"Systematic review and meta-analysis of the effect of chronic kidney disease on amputation and mortality in patients with peripheral artery disease","volume":"59","author":"Zhang","year":"2025","journal-title":"Vasc. Endovasc. Surg."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200684_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcrp.2026.200684_bib38","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/dom.14159","article-title":"Sodium-glucose co-transporter-2 inhibitors and major adverse limb events: a trial-level meta-analysis including 51 713 individuals","volume":"22","author":"Huang","year":"2020","journal-title":"Diabetes Obes. Metabol."},{"issue":"11","key":"10.1016\/j.ijcrp.2026.200684_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034175","article-title":"Comparison of new-onset peripheral artery disease in patients with type 2 diabetes exposed to sodium-glucose Cotransporter-2 inhibitors, dipeptidyl Peptidase-4 inhibitors, or glucagon-like Peptide-1 agonists: a population-based cohort Study","volume":"14","author":"Chou","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200684_bib41","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2105\/AJPH.2010.300086","article-title":"Estimated deaths attributable to social factors in the United States","volume":"101","author":"Galea","year":"2011","journal-title":"Am. J. Publ. Health"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200684_bib43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.ijcrp.2026.200684_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021456","article-title":"Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas","volume":"10","author":"Fanaroff","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200684_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jvs.2023.09.020","article-title":"Patients living farther from a tertiary care center are more likely to undergo peripheral arterial bypass for acute and chronic limb-threatening ischemia","volume":"79","author":"Zil","year":"2024","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ijcrp.2026.200684_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.avsg.2019.01.004","article-title":"African Americans are at a higher risk for limb loss but not mortality after lower extremity bypass surgery","volume":"58","author":"Yang","year":"2019","journal-title":"Ann. Vasc. Surg."},{"issue":"11","key":"10.1016\/j.ijcrp.2026.200684_bib47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.33963\/KP.a2021.0112","article-title":"Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial","volume":"79","author":"Hay\u0131ro\u011flu","year":"2021","journal-title":"Kardiol. Pol."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200684_bib48","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/00015385.2023.2223005","article-title":"The role of smart devices and mobile application on the change in peak VO(2) in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial","volume":"78","author":"Hay\u0131ro\u011flu","year":"2023","journal-title":"Acta Cardiol."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200684_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.12109","article-title":"Self-Reported social determinants of health and area-level social vulnerability","volume":"7","author":"Brignone","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijcrp.2026.200684_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119211","article-title":"Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort","volume":"405","author":"Mohammadnia","year":"2025","journal-title":"Atherosclerosis"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:03:16Z","timestamp":1793977396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S2772487526001145"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200684","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stacking in peripheral artery disease (PAD): Integrating genetics, cardiometabolic disease and social determinants of health to explain worsening PAD outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200684"}}